Evaluating the safety and effects of Remazolam Besylate in ICU patients with kidney issues
Official title: A Randomized Study of the PK/PD Properties and Safety of Remazolam Besylate for Injection in ICU Patients With Impaired Renal Function
Run by Wuhan Union Hospital, China · NCT06153498 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing how safe and effective a new medication called Remazolam Besylate is for ICU patients on ventilators, especially those with kidney problems.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 36 (estimated) |
| Sponsor | Wuhan Union Hospital, China Academic / other |
| Locations | 1 site (Wuhan, Hubei) |
| Trial ID | NCT06153498 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are intubated and mechanically ventilated patients with a BMI between 18 and 30 kg/m2 and a glomerular filtration rate indicating either impaired or normal renal function.
✕Probably not a fit
Patients with severe renal impairment (GFR < 29 ml/min/1.73m2) or those with certain serious conditions like myasthenia gravis or status asthmaticus may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the pharmacokinetic and pharmacodynamic properties of Remazolam Besylate in ICU patients who are mechanically ventilated and have either impaired or normal renal function. The study aims to compare the drug's effects and safety by monitoring hemodynamic parameters and recording any adverse events. Patients will be assessed based on their renal function, with specific criteria for inclusion and exclusion to ensure safety and relevance of results.
Why it matters
Potential benefit: If successful, this study could improve sedation management in ICU patients with renal impairment, enhancing patient safety and comfort.
How similar studies have gone: While this approach is focused on a specific patient population, similar studies evaluating sedation in ICU settings have shown promising results, indicating potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Body mass index (BMI) ≥18 and ≤ 30 kg/m2 * Being Intubated and mechanically ventilated ≤48 hours before enrollment and expected to be on a ventilator for at least 6 hours * Requirement for light to moderate sedation (a Richmond agitation-sedation scale score of -2 to 1) Patients with impaired renal function were defined as having a glomerular filtration rate of 30 to 89 ml/min/1.73m2. Patients with normal renal function were defined as having a glomerular filtration rate of 90 to 120 ml/min/1.73m2 Exclusion Criteria: * Refusal to be included * Allergy or unsuitability to any composition of study drugs or remifentanil * Living expectancy less than 48 hours * Myasthenia gravis * Status asthmaticus * Abdominal compartment syndrome * Serious hepatic dysfunction (CTP 10-15); * Chronic kidney disease with glomerular filtration rate (GFR) \< 29 ml/ min/1.73m2 * Mean blood pressure less than 65 mm Hg or the need for a continuous infusion of norepinephrine at ≥0.5 ug/kg/min to maintain Mean blood pressure ≥ 65 mm Hg * Possible requirement for surgery or bedside tracheostomy in 24 hours * Possible requirement for renal replacement therapy in 24 hours * Acute severe neurological disorder and any other condition interfering with sedation assessment * Abuse of controlled substances or alcohol * Pregnancy or lactation
Where it's running
-
Wuhan Union Hospital
Wuhan, Hubei, China Recruiting
Study contacts
- Study coordinator: You Shang, MD
- Email: you_shanghust@163.com
- Phone: +8602785351606
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing ventilator hyperinflation and vibrocompression for lung health in patients on mechanical ventilation
This study is testing whether two different lung treatments, ventilator hyperinflation and vibrocompression, can help improve lung health in patients who have been on a ventilator for a few days.
-
Inspiring Weaning: Using Breathing Muscle Training in ICU Patients
This trial tests whether inspiratory muscle training helps ICU patients on mechanical ventilation wean off ventilation more quickly.
-
Remimazolam sedation in ICU patients on mechanical ventilation
This study tests whether using remimazolam for sedation helps mechanically ventilated ICU patients recover better compared to another sedative.
-
Diaphragm stimulation to improve breathing in ICU patients on ventilators
This study is testing if a new way of stimulating the diaphragm can help ICU patients on ventilators breathe better compared to standard care.
-
Comparing two techniques for clearing mucus in patients on mechanical ventilation
This study is testing two different ways to help clear mucus from the lungs of patients on mechanical ventilation to see which method works better for their breathing.
-
Finding the best inspiratory muscle training dose for tracheostomy patients in the ICU
This trial tests different amounts of inspiratory muscle training to see if stronger breathing muscles help adults with a tracheostomy in the ICU come off ventilators faster.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.